From Process Stabilization to Plant Network Performance: Pfizer’s Journey to Operational Excellence

Colin Seller () and Richard Davis ()
Additional contact information
Colin Seller: Pfizer
Richard Davis: Pfizer

Chapter Chapter 8 in Leading Pharmaceutical Operational Excellence, 2013, pp 117-130 from Springer

Abstract: Abstract Pfizer is one of the world’s leading research-based pharmaceutical companies; discovering, developing, manufacturing and marketing innovative medicines. The company was founded in 1849, and by 2012 it had grown into a $59 billion global enterprise with more than 88,000 employees and an annual R&D spending of $7.9 billion.

Keywords: Supply Chain; Operational Excellence; Inventory Strategy; Balance Scorecard; Pharmaceutical Manufacturing (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-642-35161-7_8

Ordering information: This item can be ordered from
http://www.springer.com/9783642351617

DOI: 10.1007/978-3-642-35161-7_8

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().